Surmodics reported $20.39M in Gross Profit on Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US USD 5.5B 283M
Align Technology ALGN:US USD 617.7M 1.47M
Baxter International BAX:US USD 1.15B 310M
Bioscrip BIOS:US USD 218M 1.1M
Boston Scientific BSX:US USD 2.22B 18M
Cryolife CRY:US USD 48.74M 3.43M
Edap Tms EDAP:US EUR 6.2M 445K
Edwards Lifesciences EW:US USD 1.09B 23.6M
Haemonetics HAE:US USD 157.91M 15.85M
Johnson & Johnson JNJ:US USD 15.94B 56M
Merit Medical Systems MMSI:US USD 128.57M 6.49M
Mesa Laboratories MLAB:US USD 36.39M 5.04M
Nektar Therapeutics NKTR:US USD 18.65M 2.18M
Stryker SYK:US USD 3.26B 461M
Surmodics SRDX:US USD 20.39M 678K